Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study. Am Heart J. 2016 Dec; 182:125-134.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Acute Coronary Syndrome
Adenosine
Adenosine
Aged
Aged
Aspirin
Aspirin
Coronary Restenosis
Coronary Restenosis
Double-Blind Method
Double-Blind Method
Drug Therapy, Combination
Drug Therapy, Combination
Drug-Eluting Stents
Drug-Eluting Stents
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
Male
Male
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Risk Adjustment
Risk Adjustment
Treatment Outcome
Treatment Outcome
authors with profiles
Usman Baber